Search results
16 hours ago · 2. Novavax already has taken key steps to recovery. Novavax, after bringing in lower-than-expected vaccine revenue, last year issued a "going concern" warning that closing its doors was a possibility.
5 days ago · Vaccine uptake has plummeted since the first shots became widely available in 2021. Nearly 70% of people got the primary vaccines, compared with fewer than 20% opting for the mRNA COVID boosters ...
7 hours ago · Vaccine manufacturers Novavax and Pfizer said via email they planned to assess their accessibility options for U.S. consumers in the wake of this change and help ensure the vaccines were ...
5 days ago · Novavax (NVAX 8.92%) and Moderna (MRNA 7.32%) both entered the coronavirus vaccine race around the same time, in early pandemic days, and their shares soared -- in fact, Novavax rose the most ...
4 days ago · Additional details are available on the semaglutide profile page. DrugPatentWatch ® Generic Entry Outlook for Wegovy. Wegovy was eligible for patent challenges on December 5, 2021. By analyzing the patents and regulatory protections it appears that the earliest date for generic entry will be December 5, 2031.
4 days ago · The Novavax vaccine will be available to adults 18 and older as a primary series with two shots administered three to eight weeks apart, and it should be available to providers around the country ...
4 days ago · Novavax (NASDAQ: NVAX) has been a highly volatile stock in recent years, and that volatility is on full display again this month. Shares of the healthcare stock are up 200% since the start of May.
